Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Nippon India Nifty Pharma ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited22.48101240870211.7793
Domestic EquitiesCipla Limited10.6826647327100.6335
Domestic EquitiesDivi's Laboratories Limited10.230514612296.3748
Domestic EquitiesDr. Reddy's Laboratories Limited9.449070072589.0131
Domestic EquitiesLupin Limited5.698127825653.6784
Domestic EquitiesTorrent Pharmaceuticals Limited4.781412037245.0420
Domestic EquitiesLaurus Labs Limited4.180245038139.3791
Domestic EquitiesGlenmark Pharmaceuticals Limited3.925817329336.9825
Domestic EquitiesAurobindo Pharma Limited3.893832181936.6809
Domestic EquitiesMankind Pharma Limited3.542712999933.3733
Domestic EquitiesAlkem Laboratories Limited3.30726192531.1551
Domestic EquitiesZydus Lifesciences Limited2.958628739227.8713
Domestic EquitiesBiocon Limited2.871869120427.0537
Domestic EquitiesIPCA Laboratories Limited2.502315993123.5722
Domestic EquitiesAbbott India Limited2.1942600820.6705
Domestic EquitiesGland Pharma Limited2.00749158418.9103
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited1.75139324416.4977
Domestic EquitiesAjanta Pharma Limited1.41494844313.3286
Domestic EquitiesNatco Pharma Limited1.04361031149.8309
Domestic EquitiesGranules India Limited0.84131668927.9257
Total 99.7577 939.7529
Cash & Cash Equivalents and Net AssetsNet Current Assets0.2169 2.0431
Cash & Cash Equivalents and Net AssetsTriparty Repo0.0252 0.2374
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0002 0.0017
Total 0.2423 2.2822
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.